Enzon Pharmaceuticals, Inc. (ENZN) has a market capitalization of $4.45M and trades at $6.00. The 52-week range is 0.0477-12.99.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-7.46.
The stock has a beta of 0.08, operates in the Healthcare sector.
